论文部分内容阅读
目的:探讨肺心病合并冠心病心衰的临床治疗方法。方法:选取2010年1月～2012年1月期间我院收治的肺心病合并冠心病心衰患者74例,将其随机分为观察组和对照组,每组37例。对照组患者给予抗感染、吸氧、纠正酸碱失衡、祛痰、利尿扩血管、适当强心等常规治疗,观察组在此基础上加用低分子肝素钠和硝酸甘油,比较两组患者的临床疗效和不良反应情况。结果:经过药物治疗,观察组总有效率为91.9%,对照组总有效率为67.6%,观察组显著高于对照组,差异有统计学意义(P<0.05),且两组患者在治疗期间均未出现严重不良反应。结论:对肺心病合并冠心病心衰患者,在常规治疗的基础上加用低分子肝素钠和硝酸甘油,可明显减轻临床症状,提高治疗效果,值得临床应用和推广。
Objective: To investigate the clinical treatment of pulmonary heart disease with coronary heart disease. Methods: From January 2010 to January 2012, 74 patients with cor pulmonale and coronary heart disease who were admitted to our hospital from January 2010 to January 2012 were randomly divided into observation group and control group, with 37 cases in each group. Patients in the control group were given anti-infection, oxygen, correction of acid-base imbalance, expectorant, diuretic vasodilatation, appropriate cardiac and other conventional treatment, the observation group on the basis of the addition of low molecular weight heparin and nitroglycerin, compared two groups of patients Clinical efficacy and adverse reactions. Results: After drug treatment, the total effective rate was 91.9% in the observation group and 67.6% in the control group, the observation group was significantly higher than the control group (P <0.05), and the two groups of patients during treatment No serious adverse reactions occurred. CONCLUSIONS: In patients with cor pulmonale and heart failure due to coronary heart disease, adding low molecular weight heparin and nitroglycerin on the basis of routine treatment can significantly reduce the clinical symptoms and improve the therapeutic effect, which is worthy of clinical application and promotion.